In our hands, we observed a statistically significant upregulation of CDD expression in cancer cells cultured with platelet releasate (Figure 3), suggesting that soluble factors from platelets could increase the capacity of cancer cells to deactivate gemcitabine. Here, CDA is linked to cancer.